Drug Monitoring

Follow the links below to find information on post market monitoring of the safety of drugs.

Reviewed December 2011

Printer friendly page Printer friendly page

37 Resources Found

Results 1 to 20 displayed.     1  2 

Title:   Chief Medical Officer's Fact Sheet - Silicone gel filled Breast Implants
Publisher:   Australian Government Department of Health and Ageing
Description:   Chief Medical Officer's Fact Sheet about silicone gel filled breast implants and PIP breast implant concerns.
Date:   May 2012
Title:   Poly Implant Prothese (PIP) Breast Implants
Publisher:   Australian Government Department of Health and Ageing
Description:   List of informative links regarding Poly Implant Prothese (PIP) Breast Implants
Date:   May 2012
Title:   PIP breast implants - TGA update
Publisher:   Australian Government Department of Health and Ageing
Description:   Updated information on safety concerns with PIP breast implants
Date:   Apr 2012
Title:   PIP breast implants - TGA update
Publisher:   Australian Government Department of Health and Ageing
Description:   Updated information on safety concerns with PIP breast implants
Date:   Apr 2012
Title:   PIP breast implants - TGA update
Publisher:   Australian Government Department of Health and Ageing
Description:   Updated information on safety concerns with PIP breast implants
Date:   Apr 2012
Title:   PIP breast implants - TGA update
Publisher:   Australian Government Department of Health and Ageing
Description:   Updated information on safety concerns with PIP breast implants
Date:   Apr 2012
Title:   Poly Implant Prothese (PIP) Breast Implants: Report of the Chief Medical Officer
Publisher:   Australian Government Department of Health and Ageing
Description:   Some women may be worried about their implants and the harm that they may cause, and they may still have unanswered questions. This report aims to present the information we have at the moment, to provide answers to common questions and to assist women who have to make choices about their own PIP breast implants.
Date:   Apr 2012
Title:   Black and red salves in treating cancer
Publisher:   Australian Government Department of Health and Ageing
Description:   TGA warns consumers about the use of Black Salve in treating cancer
Date:   Mar 2012
Title:   Poly Implant Prothese (PIP) breast implants - TGA update
Publisher:   Australian Government Department of Health and Ageing
Description:   As part of the Australian Government's ongoing management of issues related to the recall of PIP silicone gel breast implants, the TGA has determined that approximately 13,000 PIP silicone gel breast implants were supplied in Australia between 1998 and 2010.
Date:   Feb 2012
Title:   Poly Implant Prothese (PIP) breast implants - TGA update
Publisher:   Australian Government Department of Health and Ageing
Description:   As part of the Australian Government's ongoing management of issues related to the recall of PIP silicone gel breast implants, the TGA has determined that approximately 13,000 PIP silicone gel breast implants were supplied in Australia between 1998 and 2010.
Date:   Feb 2012
Title:   Avastin - counterfeit injections in the USA
Publisher:   Australian Government Department of Health and Ageing
Description:   The United States Food and Drug Administration has advised that it has found instances of medical clinics in that country importing a counterfeit version of the injectable drug bevacizumab (brand name Avastin).
Date:   Feb 2012
Title:   Greenridge herbal liquid medicines: swapped labels
Publisher:   Australian Government Department of Health and Ageing
Description:   Batch 5972 of Greenridge Gastrocalm Liquid and batch 6797 of Greenridge Triplex Liquid are being recalled because the labels on these batches have been unintentionally swapped during the manufacturing process
Date:   Feb 2012
Title:   Poly Implant Prothese (PIP) breast implants - TGA update
Publisher:   Australian Government Department of Health and Ageing
Description:   Updated information on PIP breast implants
Date:   Feb 2012
Title:   Poly Implant Prothese (PIP) breast implants - the Australian perspective
Publisher:   Australian Government Department of Health and Ageing
Description:   TGA's response to safety concerns about PIP breast implants
Date:   Jan 2012
Title:   Currently no evidence of increased rupture rate for PIP breast implants in Australia, further investigations ongoing
Publisher:   Australian Government Department of Health and Ageing
Description:   The Therapeutic Goods Administration (TGA) advises Australian women that there is currently no evidence of increased rupture rate for PIP implants in this country
Date:   Jan 2012
Title:   Pneumovax 23 - updated revaccination recommendations
Publisher:   Australian Government Department of Health and Ageing
Description:   Updated revaccination recommendations following the TGA investigation of Pneumovax 23 adverse events
Date:   Dec 2011
Title:   Poly Implant Prothese silicone gel breast implants
Publisher:   Australian Government Department of Health and Ageing
Description:   The Therapeutic Goods Administration is aware that the French regulatory authority is continuing to investigate adverse events reported in patients with silicone gel breast implants manufactured by Poly Implant Prothese (PIP).
Date:   Dec 2011
Title:   Dabigatran (Pradaxa) & the risk of bleeding: new recommendations for monitoring kidney function
Publisher:   Australian Government Department of Health and Ageing
Description:   The TGA advises health professionals and consumers that, following further evaluation of international reports of bleeding with Pradaxa, new recommendations for assessing kidney function before starting this medicine and during its use are now in place.
Date:   Nov 2011
Title:   Atomoxetine (STRATTERA) - risk of increased blood pressure and/or heart rate
Publisher:   Australian Government Department of Health and Ageing
Description:   The TGA is advising health professionals and patients of important safety information regarding the risk of increased blood pressure and/or heart rate with the use of atomoxetine (STRATTERA® )
Date:   Nov 2011
Title:   Adverse drug reactions: Australian statistics on medicines
Publisher:   Australian Government Department of Health and Ageing
Description:   The Office of Product Review of the Therapeutic Goods Administration, prepared a report for incorporation into the Department of Health and Ageing publication Australian Statistics on Medicines
Date:   Sep 2011

Results 1 to 20 displayed.     1  2